CANY
CORT icon

Caxton Associates (New York)’s Corcept Therapeutics CORT Stock Holding History

Caxton Associates (New York)’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$536K Buy
+10,632
New +$557K 0.02% 318
2020
Q3 		– Sell
-53,222
Closed -$895K – 346
2020
Q2 		$895K Buy
53,222
+30,102
+130% +$423K 0.09% 75
2020
Q1 		$275K Buy
23,120
+1,447
+7% +$17.9K 0.05% 277
2019
Q4 		$262K Buy
+21,673
New +$302K 0.05% 304
2017
Q4 		– Sell
-10,300
Closed -$199K – 369
2017
Q3 		$199K Buy
+10,300
New +$154K 0.01% 472

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return